Integration of US innovations into European markets.
We help innovative pharmaceutical and medical device companies enter and scale across European markets — faster, smarter and with shared ownership.
The innovation gap we bridge.
The global heartbeat of research and development for innovative pharmaceuticals and medical devices lies in the USA. A consequence of continuous backward integration and resource scarcity in startups that focus their efforts on market penetration in the USA after FDA approval is the delayed availability of US innovations outside the USA – creating a significant gap in the global market.
CCI was founded to bridge this gap. If our partners cannot come to Europe — we go to them.
Not a fund.
A strategic partner.
We go beyond traditional investment or advisory models. As a European partner, we actively take responsibility for the success of our partners’ products in Europe.
01
We invest our own capital
Not third-party money. We become co-owners because we believe in your future.
02
We take full responsibility
Regulatory, distribution, commercialization — we own the European execution.
03
We catalyze the upscaling
Speed to market is critical. We focus on the fastest possible penetration.
Shared risk. Shared execution. Shared success.
Your path into Europe.
From FDA approval to European market presence — we handle every step of the process.
Step 01
CCI Partnership. We invest capital and become co-owners.
Step 02
FDA Approval. Your full attention is focused on achieving maximum success in the US.
Step 03
EMA Approval or CE Mark. You are allowed to market your product in Europe.
Step 04
Market Entry. Distribution across 27+ European markets.
Speed is a critical success factor.
Fast market entry secures early brand positioning, market access, and competitive advantage. We focus on the fastest possible market penetration — covering regulatory, distribution, and commercialization.
When our partner succeeds, we succeed.
This alignment forms the foundation for sustainable, long-term value creation — for companies and for patients waiting for innovative treatments.
Early Brand Positioning
First-mover advantage establishes your presence before competitors enter the market.
Unified Market Access
Single partnership grants access to 27+ European countries through one coordinated effort.
Early Brand Positioning
Speed creates lasting market position. We ensure you're ahead from day one.
Areas of expertise.
Specialized in the commercialization of pharmaceuticals and medical devices across Europe.
Pharmaceuticals
Good Distribution Practice (GDP)
Following approval, products can be distributed across EU member states, with separate approvals required for the UK and Switzerland. We implement GDP-compliant storage and transport and ensure the availability of your product in Europe.
Medical Devices
Full commercialization across Europe
Medical devices fall into two categories: devices used by physicians as part of treatment and devices used by patients independently after instruction. CCI specializes in commercializing both categories.
Ready to enter Europe? Contact us.
Let's discuss how CCI can accelerate your European market entry. We're looking for partners whose future we believe in.
Just fill the form and we will contact you.